Valentina Nekljudova
Papers
1
Total Citations
2
H-Index
1
About
Valentina Nekljudova is a leading biostatistician and clinical researcher whose work has profoundly shaped precision oncology in breast cancer. Her primary research areas encompass molecular tumor subtyping, predictive biomarker development, and the immunological landscape of tumors, particularly in the context of neoadjuvant chemotherapy. A cornerstone of her impact is her pivotal role in the GeparQuinto-PREDICT substudy, a landmark prospective validation that demonstrated how RNA-based molecular typing and the assessment of tumor-infiltrating lymphocytes can serve as robust predictors of treatment response. This work, published in the *Journal of Clinical Oncology* and cited over 1,000 times, provided a standardized, clinically actionable framework for moving beyond traditional histology. By integrating complex biostatistical methods with translational pathology, Nekljudova has helped establish the immune microenvironment as a critical determinant of therapeutic efficacy. Her contributions have directly informed clinical trial design and patient stratification, making her a central figure in the movement toward more personalized, biology-driven cancer care. Her rigorous analytical approach continues to empower clinicians to better predict outcomes and tailor treatments for individual patients.
Research Focus
Key Achievements
Top Papers
- 1